Atrial Fibrillation

Atrial fibrillation essentials

  • Atrial fibrillation, often called AF or AFib, is an irregular rhythm in the heart’s upper chambers that may be intermittent, persistent, symptomatic, or silent.
  • Palpitations, an irregular pulse, or a wearable alert can prompt evaluation, but a clinician-reviewed ECG is needed to confirm AF.
  • Stroke prevention, rate or rhythm treatment, and procedures are individualized; no score, pulse, or article can choose them for you.
  • Possible stroke signs, even if they resolve, require emergency services immediately and no self-driving.
  • Never start, stop, skip, or substitute an anticoagulant, aspirin, or rhythm medicine based on general information.

Stroke or another emergency? Act now

Call emergency services immediately for sudden facial droop, arm or leg weakness, trouble speaking or understanding, sudden balance or vision change, or another possible stroke sign. Note when the person was last known well. Do not drive them yourself, and do not wait to see whether symptoms disappear. A transient episode may still be a medical emergency.

New chest pain, severe breathing difficulty, fainting, or unresponsiveness also requires emergency services. Do not take an extra heart or blood-thinning medicine, use a home maneuver, or wait for a wearable reading to change before seeking help. Emergency action does not depend on whether AF has previously been diagnosed.

What atrial fibrillation is

In atrial fibrillation, electrical activity in the heart’s upper chambers becomes disorganized, producing an irregular rhythm. The lower chambers may also beat quickly or irregularly. AF can occur in episodes, continue for longer periods, or become a sustained rhythm. The clinical label depends on documented rhythm and the person’s course, not on how the pulse feels.

AF matters because it can affect symptoms and heart function and can raise the chance of a clot-related stroke in some people. That does not mean every person has the same risk or needs the same treatment. Age, previous stroke, other heart and vascular conditions, bleeding history, kidney or liver function, medicines, and preferences all contribute to decisions.

An irregular rhythm is not automatically AF. Other rhythm disturbances, extra beats, illness, medicines, anxiety, thyroid disease, sleep problems, alcohol, and other factors can produce palpitations or abnormal readings. A proper evaluation identifies the rhythm and looks for contributing conditions.

Symptoms may come and go or be absent

People may notice a racing, fluttering, pounding, or irregular heartbeat. Fatigue, shortness of breath, light-headedness, reduced exercise tolerance, weakness, or chest discomfort can occur. Symptoms may start and stop, vary between episodes, or be subtle. Some people have no symptoms and learn about AF during an examination or test for another reason.

Symptoms alone cannot confirm AF, show how long it has been present, or determine stroke risk. Conversely, feeling well does not make a documented rhythm unimportant. The intensity of palpitations does not reliably show the speed of the rhythm or the seriousness of the underlying situation.

Record when symptoms began, what you were doing, how long they seemed to last, and whether there were chest, breathing, fainting, or neurologic symptoms. That information can help clinicians choose monitoring. It is not a reason to delay emergency care or adjust medicine on your own.

How AF is confirmed

A clinician reviews the history, examines the person, and seeks ECG evidence of the rhythm. A standard ECG may capture AF if it is present at that moment. When episodes are intermittent, longer monitoring may be used. Additional testing can help assess heart structure, thyroid function, electrolytes, kidney or liver function, or other possible contributors.

A smartwatch, fitness tracker, home ECG, or irregular-rhythm notification can be useful evidence to bring to a visit. It is a prompt for evaluation, not a stand-alone diagnosis. Artifact, movement, skin contact, device limits, and other rhythms can affect a tracing. Current guidance calls for visual confirmation of ECG signals by a qualified clinician.

Do not rely on a screenshot, pulse count, or phone application to label the rhythm. If an alert repeats without emergency symptoms, contact a clinician promptly and follow instructions for saving or transmitting the record. If emergency symptoms occur, seek emergency care regardless of what the device displays.

Types and episode patterns

Clinicians may describe AF by the stage of the condition and by whether episodes end on their own, require treatment to end, or continue over time. These terms help communicate the rhythm’s pattern and guide care. They do not provide a home prognosis or tell a person which treatment is appropriate.

An episode’s apparent duration on a wearable is not enough to self-classify AF. Monitoring may not capture the true beginning or end, and a device-detected atrial high-rate episode is not automatically the same as clinically confirmed AF. The treating team interprets the rhythm evidence and the broader context.

Patterns may change, and symptoms do not always track rhythm burden. Follow-up can assess whether the rhythm, symptoms, heart function, or related conditions have changed. Avoid using a generic heart-rate or episode-duration threshold as permission to stay home when serious symptoms are present.

Stroke and bleeding risk are individualized

AF can allow blood to pool and form a clot that may travel to the brain. Clinicians assess factors associated with clot-related stroke and discuss whether an anticoagulant is likely to offer more benefit than harm. They also consider bleeding risks, interactions, kidney and liver function, falls and frailty, previous bleeding, procedures, and the person’s priorities.

Risk scores can organize part of that conversation, but an online result is not a prescription. A score does not capture every clinical issue and should not be used to start, stop, or choose an anticoagulant or aspirin. Aspirin is not an interchangeable substitute for prescribed anticoagulation.

Stroke risk can remain relevant even when symptoms improve or rhythm treatment appears successful. An ablation or cardioversion does not automatically remove the need for stroke-prevention review. Only the treating clinician can decide whether a medicine remains appropriate and how interruptions for procedures should be handled.

Broad treatment roles

Care may address the heart rate, the rhythm itself, clot-related stroke prevention, symptoms, contributing conditions, and risk factors. Options can include medicines, cardioversion, catheter procedures, and other interventions for selected people. The best combination depends on rhythm pattern, symptom burden, heart structure and function, other illnesses, safety, preferences, and access.

Rate control and rhythm control answer different clinical goals, and neither has one universal medicine. Cardioversion and ablation require evaluation and planning; they are not selected from symptoms or a consumer checklist. No procedure guarantees a permanent cure, and follow-up remains important.

Never start, stop, skip, double, borrow, or substitute an anticoagulant, aspirin, rate-control medicine, or rhythm-control medicine based on this page. If cost, side effects, pregnancy plans, an upcoming procedure, illness, or missed doses create concern, contact the prescribing team promptly for specific instructions.

Monitoring and daily life

Monitoring may involve clinic ECGs, a wearable medical monitor, symptom notes, heart imaging, or tests related to medicines and other conditions. The plan should explain which findings to report and who will review them. Consumer devices can supplement that plan but should not replace it.

Sleep apnea, blood pressure, diabetes, coronary disease, heart failure, thyroid disease, alcohol exposure, body composition, activity, smoking, and other factors may be relevant. Addressing them can be part of comprehensive care, but this does not justify a universal alcohol limit, exercise prescription, or weight target from an article.

Work, disability, language, medicine cost, transport, caregiving, and access to monitoring can affect treatment. Tell the care team what is feasible. A safer plan fits the person’s circumstances rather than treating barriers or recurring symptoms as a failure of effort.

Questions for the care team

Ask what ECG evidence confirmed AF, whether longer monitoring is needed, and what type or stage the clinician is using. Clarify which symptoms reflect the rhythm and whether another condition may be contributing. Ask what changes should prompt a routine message, urgent contact, or emergency services.

Discuss how stroke and bleeding risks were assessed and what role each medicine has. Ask about interactions with nonprescription medicines and supplements, monitoring needs, missed-dose instructions, procedures, travel, and access problems. Do not wait for an appointment to report serious bleeding or emergency symptoms.

If cardioversion or ablation is discussed, ask about its goal, alternatives, preparation, follow-up, and how it affects, not automatically ends, the stroke-prevention plan. Bring wearable reports if requested, but also describe symptoms and their timing. Shared decisions combine clinical evidence with the person’s goals and concerns.

Population and setting boundaries

This guide centers adults with suspected or established AF. Children, pregnancy or the postpartum period, congenital heart disease, AF after surgery, and critical illness require population- and setting-specific guidance. Advice from a stable outpatient context may not apply during acute illness or hospitalization.

Age, frailty, falls, previous stroke or bleeding, valve disease, kidney or liver function, and interacting medicines can materially change decisions. Symptoms can also be described or recognized differently across individuals. No stereotype based on sex, gender, race, ethnicity, disability, fitness, or body size should be used to rule AF in or out.

Official sources